Transdermal administration of buprenorphine for treatment of dependence withdrawal

摘要

Disclosed is the use of buprenorphine for the manufacture of a transdermal dosage form for the treating of withdrawal or abstinence syndrome in a drug dependent or opioid tolerant patient in need of such treatment, wherein the patient is a pregnant woman. Also disclosed is a kit comprising a first, second and third transdermal dosage form containing 5, 10 and 10 mg respectively, or 10, 20 and 20 mg respectively.